Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 7/20 | 0.76 |
| ▸ | EPHX2 | P34913 | 6/20 | 0.76 |
| ▸ | CNR1 | P21554 | 5/20 | 0.73 |
| ▸ | CNR2 | P34972 | 4/20 | 0.73 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14102773 | 0.92 | EPHX2 (0.72) | FAAHEPHX2CNR1CNR2TRPV1 | |
| SCHEMBL18328442 | 0.92 | EPHX2 (0.72) | FAAHEPHX2CNR1CNR2TRPV1 | |
| SCHEMBL12980257 | 0.92 | EPHX2 (0.72) | FAAHEPHX2CNR1CNR2TRPV1 | |
| SCHEMBL22558573 | 0.86 | EPHX2 (1.00) | FAAHEPHX2CNR1CNR2TRPV1 | |
| SCHEMBL14102656 | 0.86 | EPHX2 (0.65) | FAAHEPHX2CNR1CNR2TRPV1 | |
| SCHEMBL18248572 | 0.86 | EPHX2 (1.00) | FAAHEPHX2CNR1CNR2TRPV1 | |
| SCHEMBL3675310 | 0.86 | EPHX2 (1.00) | FAAHEPHX2CNR1CNR2TRPV1 | |
| SCHEMBL15915089 | 0.86 | HPGD (0.67) | FAAHEPHX2 | |
| SCHEMBL26112457 | 0.85 | CNR1 (0.88) | FAAHEPHX2CNR1CNR2TRPV1 | |
| Hydrochloric Acid SCHEMBL8002990 | 0.85 | EPHX2 (0.97) | FAAHEPHX2CNR1CNR2TRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250281406-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR DELIVERY OF BIOLOGICALLY ACTIVE AGENTS | ROYAL MELBOURNE INSTITUTE OF TECHNOLOGY (AU) | 2025-09-11 | — | — | US | disclosed |
| CN-119403572-A | Compounds, compositions and methods for delivering bioactive agents | 皇家墨尔本理工大学 | 2025-02-07 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250281406-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR DELIVERY OF BIOLOGICALLY ACTIVE AGENTS | LIPA, LIPG, SGMS1 | FAAH 1024/4885EPHX2 917/4885CNR1 1933/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.